BackPediatrix Medical Group Overview

Pediatrix Medical Group Other Current Assets

Latest other current assets for MD: $21M.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$21.07M
7.00% YoYΔ $1.38M vs prior year quarter

Peer average

Loading

Pediatrix Medical Group Other Current Assets History

Loading

Pediatrix Medical Group vs. peers: Other Current Assets Comparison

Loading

Pediatrix Medical Group Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Pediatrix Medical Group (MD) FAQ

Pediatrix Medical Group's other current assets stands at $21M as of March 2026. That compares with $20M in the prior-year period — up 7.0% year over year. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Pediatrix Medical Group reported $21M in other current assets versus $20M a year earlier — a 7.0% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

That compares with $20M in the prior-year period — up 7.0% year over year. Sustained growth in other current assets can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Pediatrix Medical Group's other current assets evolved across reporting periods, while the comparison chart places MD next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, other current assets is commonly used to spot outliers. Pediatrix Medical Group's reading of $21M is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.